|
ZNF322A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.38760000343441E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.1790000000198E-06 |
| Normal-vs-Stage2 |
2.432400E-02 |
| Normal-vs-Stage3 |
5.859700E-02 |
| Normal-vs-Stage4 |
7.822000E-03 |
| Stage1-vs-Stage2 |
5.146400E-01 |
| Stage1-vs-Stage3 |
3.506000E-01 |
| Stage1-vs-Stage4 |
3.286600E-01 |
| Stage2-vs-Stage3 |
2.806000E-01 |
| Stage2-vs-Stage4 |
7.470000E-01 |
| Stage3-vs-Stage4 |
1.379840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.47979999978831E-07 |
| Normal-vs-AfricanAmerican |
5.88859999999247E-05 |
| Normal-vs-Asian |
3.992400E-04 |
| Caucasian-vs-AfricanAmerican |
7.675400E-01 |
| Caucasian-vs-Asian |
3.231200E-01 |
| AfricanAmerican-vs-Asian |
5.010000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.52339999965379E-07 |
| Normal-vs-Female |
2.87200000004262E-06 |
| Male-vs-Female |
3.313200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.416470E-03 |
| Normal-vs-Extreme_Weight |
1.801130E-03 |
| Normal-vs-Obese |
2.23259999998504E-06 |
| Normal-vs-Extreme_Obese |
2.426500E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.818400E-01 |
| Normal_Weight-vs-Obese |
2.202600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.006200E-01 |
| Extreme_Weight-vs-Obese |
7.246100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.994800E-01 |
| Obese-vs-Extreme_Obese |
3.517400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.09260000000522E-06 |
| Normal-vs-Age(41-60Yrs) |
2.32189999449517E-08 |
| Normal-vs-Age(61-80Yrs) |
3.57750000000712E-05 |
| Normal-vs-Age(81-100Yrs) |
8.292800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.990200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.295610E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.384500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.793790E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.564000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.805500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.79889469776163E-11 |
| Normal-VS-Type2 PRCC |
2.661200E-01 |
| Normal-VS-KIRP CIMP |
1.048430E-01 |
| Normal-VS-Unclassified PRCC |
2.769600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.7287000005134E-07 |
| Type1 PRCC-VS-KIRP CIMP |
3.260600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.830300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.974420E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.410200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.769000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.459700E-03 |
| Normal-vs-N1 |
2.162600E-03 |
| Normal-vs-N2 |
3.133200E-01 |
| N0-vs-N1 |
8.823800E-02 |
| N0-vs-N2 |
7.306000E-01 |
| N1-vs-N2 |
3.182600E-01 |
|
|
